Acute leukemias and Burkitt's lymphoma. Present status of therapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D002822:Choriocarcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000628:therapy
D000970:Antineoplastic Agents; D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin